The FDA has issued a CRL to Replimmune regarding the BLA for vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

The prevalence of frailty was 33% among a US-wide cohort of patients with RMDs, with the highest rates found among those with fibromyalgia or CTDs.

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

The HHS is directing the Organ Procurement and Transplantation Network to implement new safety measures following accusations of negligence.

A total of 4 new recommendations are included as part of the American Academy of Dermatology’s atopic dermatitis guideline updates.

Tumor necrosis factor inhibitor use in patients with IMIDs did not increase the risk of de novo heart failure or worsen existing heart failure.

Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

An updated human papillomavirus-positive oropharyngeal carcinoma staging classification improves prognostication and management.

Remote use of 3D total body photography has about 85% diagnostic accuracy for general skin diseases when compared with routine examination.

The FDA will revoke 52 food standards affecting fruit, vegetable, and dairy products deemed "obsolete and unnecessary." ...